Chip Electrophoresis as a method for quantifying total microalbuminuria

Clinical Chemistry

Volumn 52, Issue 11, 2006, Pages 2141-2146

  Chan, Owen T M ^a,b   Herold, David A ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BOVINE SERUM ALBUMIN;

ACCURACY; AUTOANALYSIS; CALIBRATION; CHICKEN; CONFERENCE PAPER; ELECTROPHORESIS; HUMAN; MICROALBUMINURIA; MICROCHIP ANALYSIS; MICROFLUIDIC ANALYSIS; NONHUMAN; QUANTITATIVE ANALYSIS; URINALYSIS;

ALBUMINURIA; ANIMALS; CALIBRATION; CATTLE; CHICKENS; ELECTROPHORESIS, MICROCHIP; HUMANS; IMMUNOASSAY; MOLECULAR WEIGHT; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

BOS TAURUS;

EID: 33750451243     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.072801     Document Type: Conference Paper

References (29)

1. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH. Diabetic nephropathy. Diabetes Care 2003;26(Suppl 1):S94-8.
2. Anavekar NS, Gans DJ, Berl T, Rohde RD, Cooper W, Bhaumik A, et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int Suppl 2004:S50-5.
3. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001;249:519-26.
4. Janssen WM, Hillege H, Pinto-Sietsma SJ, Bak AA, DeZeeuw D, de Jong PE. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. Clin Chem Lab Med 2000;38:1107-10.
5. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984;310:356-60.
6. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
7. Mogensen CE, Poulsen PL. Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2. Kidney Int Suppl 2004:S40-1.
8. Ritz E. Heart and kidney: fatal twins? Am J Med 2006;119:S31-9.
9. Yamada T, Komatsu M, Komiya I, Miyahara Y, Shima Y, Matsuzaki M, et al. Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study. Diabetes Care 2005;28:2733-8.
10. Dinneen SF, Gerstein HC, The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus, A systematic overview of the literature. Arch Intern Med 1997;157:1413-8.
11. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B, et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 2000;23(Suppl 2):B35-9.
12. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003;63:225-32.
13. Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, et al. Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. J Hypertens 2006;24:403-8.
14. Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT Study. J Am Soc Nephrol 2006;17(Suppl 2):S90-7.
15. Comper WD, Jerums G, Osicka TM. Deficiency in the detection of microalbuminuria by urinary dipstick in diabetic patients. Diabetes Care 2003;26:3195-6.
16. Comper WD, Osicka TM. Albumin-like material in urine. Kidney Int Suppl 2004;365-6.
17. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 2004;50:2286-91.
18. Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 2006;39:143-51.
19. Comper WD, Jerums G, Osicka TM. Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Ciin Biochem 2004;37:105-11.
20. Comper WD, Osicka TM, Jerums G. High prevalence of immunounreactive intact albumin in urine of diabetic patients. Am J Kidney Dis 2003;41:336-42.
21. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL. Coelution of other proteins with albumin during size-exclusion HPLC: implications for analysis of urinary albumin. Clin Chem 2006;52:389-97.
22. Bousse L, Mouradian S, Minalla A, Yee H, Williams K, Dubrow R. Protein sizing on a microchip. Anal Chem 2001;73:1207-12.
23. Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, et al., Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11-22 of chromosome 4. J Biol Chem 1986;261:6747-57.
24. Brown JR. Structural origins of mammalian albumin. Fed Proc 1976;35:2141-4.
25. Kelly JF, Locke SJ, Ramaley L, Thibault P. Development of electrophoretic conditions for the characterization of protein glycoforms by capillary electrophoresis-electrospray mass spectrometry. J Chromatogr A 1996;720:409-27.
26. Nisbet AD, Saundry RH, Moir AJ, Fothergill LA, Fothergill JE. The complete amino-acid sequence of hen ovalbumin. Eur J Biochem 1981;115:335-45.
27. Ricos C, Jimenez CV, Hernandez A, Simon M, Perich C, Alvarez V, et al. Biological variation in urine samples used for analyte measurements. Clin Chem 1994;40:472-7.
28. Peters T, Jr. How should we measure the albumin in urine? Clin Chem 2006;52:555-6.
29. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004;65:1850-5.